Litigation Summary and Analysis: Bayerische Motoren Werke Aktiengesellschaft v. Onesta IP, LLC (26-1338) Executive Summary Bayerische Motoren Werke Aktiengesellschaft (BMW) […]

The global rare disease treatment market, a sector born from legislative incentives to address profound unmet needs, is on an

Executive Summary: The Verdict on France’s Medical Revolution The global pharmaceutical landscape stands at the precipice of a new era,

1. The Economics of Time in Biopharma Biopharmaceutical asset valuation rests on a single, volatile variable: the duration of market

In the world of pharmaceuticals a patent represents the culmination of a decade or more of painstaking research, countless failed

A drug patent is more than a legal document; it is the financial bedrock upon which entire companies are built.

Section 1: The Fundamental Question of Patentability for Drug Combinations 1.1 Introduction: Beyond a Simple “Yes” – The Strategic Imperative

Section 1: Introduction: The Value and Paradox of Second Acts in Pharmacology The Rise of Drug Repurposing Drug repurposing, also

The countdown is relentless. For every blockbuster drug that reaches the market, a clock starts ticking, marking the finite years